The Aug. 2, 2005 file photo shows the logo of Swiss pharmaceutics company Roche in Basel, Switzerland. (AP Photo/Keystone, Steffen Schmidt)
Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
Swiss pharmaceutical giant Roche said Monday that U.S. regulators had issued emergency authorization to use its not-yet-approved diagnostic test for detecting the Zika virus in certain circumstances.The U.S. Food and Drug Administration (FDA) issued a so-called Emergency Use Authorization for the LightMix Zika rRT-PCR test, even though it has yet to receive official clearance, allowing certified labs to use it in the hunt for the mosquito-borne virus.More than 2,500 people in the United States have been diagnosed with Zika, along with more than 9,000 in Puerto Rico and other U.S. territories, according to the U.S. Centers for Disease Control and Prevention.
FOLLOW THIS ARTICLE